Adage Capital Partners Gp, L.L.C. Catalent, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

$54.6 Billion
Q3 2024

A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Catalent, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 1,048,594 shares of CTLT stock, worth $66.6 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

1,048,594

Previous 1,345,794 22.08%

Holding current value

$66.6 Million

Previous $75.7 Million 16.07%

% of portfolio

0.12%

Previous 0.14%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$56.16 - $60.96 $16.7 Million - $18.1 Million	-297,200 Reduced 22.08%	1,048,594 $63.5 Million
Q2 2024 Aug 14, 2024	BUY	$53.58 - $57.02 $27.8 Million - $29.6 Million	518,494 Added 62.67%	1,345,794 $75.7 Million
Q1 2024 May 15, 2024	BUY	$42.56 - $59.82 $23.6 Million - $33.2 Million	554,229 Added 202.96%	827,300 $46.7 Million
Q4 2023 Feb 14, 2024	SELL	$32.18 - $46.57 $6.64 Million - $9.61 Million	-206,430 Reduced 43.05%	273,071 $12.3 Million
Q3 2023 Nov 14, 2023	BUY	$44.2 - $50.2 $3.2 Million - $3.63 Million	72,308 Added 17.76%	479,501 $21.8 Million
Q2 2023 Aug 14, 2023	SELL	$31.86 - $67.26 $9.17 Million - $19.4 Million	-287,807 Reduced 41.41%	407,193 $17.7 Million
Q1 2023 May 15, 2023	BUY	$45.44 - $74.26 $23.3 Million - $38 Million	512,000 Added 279.78%	695,000 $45.7 Million
Q4 2022 Feb 14, 2023	BUY	$41.39 - $81.0 $4.16 Million - $8.13 Million	100,400 Added 121.55%	183,000 $8.23 Million
Q3 2022 Nov 14, 2022	SELL	$72.36 - $113.1 $7.53 Million - $11.8 Million	-104,000 Reduced 55.73%	82,600 $5.98 Million
Q2 2022 Aug 15, 2022	SELL	$87.2 - $114.05 $34,880 - $45,620	-400 Reduced 0.21%	186,600 $20 Million
Q1 2022 May 16, 2022	BUY	$94.19 - $124.49 $433,274 - $572,654	4,600 Added 2.52%	187,000 $20.7 Million
Q4 2021 Feb 14, 2022	SELL	$119.57 - $139.07 $23,914 - $27,814	-200 Reduced 0.11%	182,400 $23.4 Million
Q3 2021 Nov 15, 2021	SELL	$109.17 - $142.35 $283,842 - $370,110	-2,600 Reduced 1.4%	182,600 $24.3 Million
Q2 2021 Aug 16, 2021	BUY	$100.34 - $115.69 $2.06 Million - $2.37 Million	20,500 Added 12.45%	185,200 $20 Million
Q1 2021 May 17, 2021	BUY	$101.51 - $125.27 $812,080 - $1 Million	8,000 Added 5.11%	164,700 $17.3 Million
Q4 2020 Feb 16, 2021	BUY	$85.88 - $105.36 $68,704 - $84,288	800 Added 0.51%	156,700 $16.3 Million
Q3 2020 Nov 16, 2020	BUY	$72.74 - $92.5 $11.3 Million - $14.4 Million	155,900 New	155,900 $13.4 Million

Others Institutions Holding CTLT

# of Institutions

509

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.

Account

Adage Capital Partners Gp, L.L.C. Catalent, Inc. Transaction History